On Tuesday, Tempest Therapeutics Inc (NASDAQ: TPST) opened higher 2.02% from the last session, before settling in for the closing price of $0.88. Price fluctuations for TPST have ranged from $0.70 to $6.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 29.54% at the time writing. With a float of $39.62 million, this company’s outstanding shares have now reached $43.64 million.
In an organization with 17 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tempest Therapeutics Inc (TPST) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tempest Therapeutics Inc is 9.21%, while institutional ownership is 5.13%. The most recent insider transaction that took place on Aug 12 ’24, was worth 426,993. Before that another transaction happened on Aug 08 ’24, when Company’s 10% Owner sold 400,000 for $1.35, making the entire transaction worth $540,040. This insider now owns 597,940 shares in total.
Tempest Therapeutics Inc (TPST) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.39% during the next five years compared to 62.66% growth over the previous five years of trading.
Tempest Therapeutics Inc (NASDAQ: TPST) Trading Performance Indicators
Check out the current performance indicators for Tempest Therapeutics Inc (TPST). In the past quarter, the stock posted a quick ratio of 1.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.54, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.04 in one year’s time.
Technical Analysis of Tempest Therapeutics Inc (TPST)
Let’s dig in a bit further. During the last 5-days, its volume was 1.32 million. That was better than the volume of 1.22 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 23.13%. Additionally, its Average True Range was 0.07.
During the past 100 days, Tempest Therapeutics Inc’s (TPST) raw stochastic average was set at 22.27%, which indicates a significant decrease from 33.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.45% in the past 14 days, which was lower than the 76.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8857, while its 200-day Moving Average is $1.6478. However, in the short run, Tempest Therapeutics Inc’s stock first resistance to watch stands at $0.9263. Second resistance stands at $0.9556. The third major resistance level sits at $0.9937. If the price goes on to break the first support level at $0.8589, it is likely to go to the next support level at $0.8208. The third support level lies at $0.7915 if the price breaches the second support level.
Tempest Therapeutics Inc (NASDAQ: TPST) Key Stats
There are currently 43,642K shares outstanding in the company with a market cap of 39.15 million. Presently, the company’s annual sales total 0 K according to its annual income of -29,490 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -10,560 K.
